Abstract
Several methods involving skin reactions are discussed in other chapters, such as
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References and Further Reading
NC/Nga Mouse as Model for Atopic Dermatitis
Aioi A, Tonogaito H, Suto H, Hamada K, Ra CR, Ogawa H, Maibach H, Matsuda H (2001) Impairment of skin barrier function in NC/Nga Tnd mice as a possible model for atopic dermatitis. Br J Dermatol 144:12–18
Arai I, Takano N, Hashimoto Y, Futaki N, Sugimoto M, Takahashi N, Inoue T, Nakaike S (2004) Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis. Eur J Pharmacol 505:229–235
Barton D, Hogen-Esch H, Weih F (2000) Mice lacking the transcription factor ReIB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur J Immunol 30:2323–2332
Chan LS, Robinson N, Xu L (2001) Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 117:977–983
Herz U, Schnoy N, Borelli S, Weigl L, Käsbohrer U, Daser A, Wahn U, Köttgen E, Ranz H (1998) A human-SCID mouse model for allergic immune response. Bacterial superantigen enhances skin inflammation and suppresses IgE production. J Invest Dermatol 110:224–231
Hiroi J, Sengoku T, Morita K, Kishi S, Sato S, Ogawa T, Tsudzuki M, Wada A, Esaki K (1998) Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC/Nga mice. Jpn J Pharmacol 76:175–183
HogenEsch H, Gijbels MJ, Offerman E, van Hooft J, van Bekkum DW, Zurcher C (1993) A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am J Pathol 143:972–982
Hossen MA, Fujii Y, Ogawa M, Takubo M, Tsumuro T, Kamei C (2005) Effect of loratadine on mouse models of atopic dermatitis associated pruritus. Int Immunopharmacol 5:1331–1336
Iwasaki T, Tanaka A, Itakura A, Yamashita N, Ohta K, Matsuda H, Onuma M (2001) Atopic NC/Nga mice as a model for allergic asthma: severe allergic responses by single intranasal challenge with protein antigen. J Vet Med Sci 63:413–419
Kohara Y, Tanabe K, Matsuoka K, Kanda N, Matsuda H, Karasuyama H, Yonekawa H (2001) A major determinant quantitative-trait locus responsible for atopic dermatitis-like skin lesions in NC/Nga mice is located on chromosome 9. Immunogenetics 53:15–21
Konishi H, Tsutsui H, Murakami T, Yumikura-Futatsugi S, Yamanaka KI, Tanaka M, Iwakura Y, Suzuki N, Takeda K, Akira S, Nakanishi K, Mizutani H (2002) IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc Natl Acad Sci U S A 99:11340–11345
Kotani M, Matsumoto M, Fujita A, Higa S, Wang W, Suemura M, Kishimoto T, Tanaka T (2000) Persimmon leaf extract and astragalin inhibit development of dermatitis and IgE elevation in NC/Nga mice. J Allergy Clin Immunol 106:159–166
Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, Hiroi J, Matsumoto M, Ushio H, Saito S, Askenase PW, Ra C (1997) Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9:461–466
Matsumoto M, Ra C, Kawamoto K, Sato H, Itakura A, Sawada J, Ushio H, Mitsuishi K, Hikasa Y, Matsuda H (1999) IgE hyperproduction through enhanced tyrosine phosphorylation of janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. J Immunol 162:1056–1063
Mihara K, Kuratani K, Matsiu T, Nakamura M, Yokota K (2004) Vital role of the itch-scratch response in development of spontaneous dermatitis in NC/Nga mice. Br J Dermatol 151:335–345
Natori K, Tamari M, Watanabe O, Onouchi Y, Shiomoto Y, Kubo S, Nakamura Y (1999) Mapping of a gene responsible for dermatitis in NOA (Naruto Research Institute Otsuka Atrichia) mice, an animal model of allergic dermatitis. J Hum Genet 44:372–376
Ohmura T, Hayashi T, Satoh Y, Konomi A, Jung B, Satoh H (2004) Involvement of substance P in scratching behaviour in an atopic dermatitis model. Eur J Pharmacol 491:191–194
Sonkoly E, Muller A, Lauerma AI, Pivarsci A, Soto H, Kemeny L, Alenius H, Dieu-Nosjean MC, Meller S, Rieker J, Steinhoff M, Hoffmann TK, Ruzicka T, Zlotnik A, Homey B (2006) IL 31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 117:411–417
Suto H, Matsuda H, Mitsuishi K, Hira K, Uchida T, Unno T, Ogawa H, Ra C (1999) NC/Nga mice: a mouse model for atopic dermatitis. Int Arch Allergy Immunol 120(Suppl 1):70–75
Takano N, Arai I, Hashimoto Y, Kurachi M (2004) Evaluation of antipruritic effects of several agents on scratching behavior by NC/Nga mice. Eur J Pharmacol 452:159–165
Takaoka A, Arai I, Sugimoto M, Yamaguchi A, Tanaka M, Nakaike S (2005) Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis. Eur J Pharmacol 516:180–181
Takaoka A, Arai I, Sugimoto M, Honma Y, Futaki N, Nakamura A, Nakaike S (2006) Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis. Exp Dermatol 15:161–167
Tsudzuki M, Watanabe N, Wada A, Nakane Y, Hiroi J, Matsuda H (1997) Genetic analyses for dermatitis and IgE hyperproduction in the NC/Nga mouse. Immunogenetics 47:88–90
Vestergaard C, Yoneyama H, Murai M, Nakamura K, Tamaki K, Yoshie O, Irimura T, Mizutani H, Matsushima K (1999) Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 104:1097–1105
Vestergaard C, Yoneyama H, Matsushima K (2000) The NC/Nga mouse: a model for atopic dermatitis. Mol Med Today 6:209–210
Watanabe O, Natori K, Tamari M, Shiomoto Y, Kubo S, Nakamura Y (1999) Significantly elevated expression of PF4 (platelet factor 4) and eotaxin in the NOA mouse, a model of atopic dermatitis. J Hum Genet 44:173–176
Motheaten Mice
Green MC, Shultz LD (1975) Motheaten, an immunodeficient mutant of the mouse. I Genetics and pathology. J Hered 66:250–258
Kovarik J, Kuntz L, Ryffel B, Borel JF (1994) The viable motheaten (mev) mouse – a new model for arthritis. J Autoimmun 7:575–588
Shultz LD (1988) Pleiotropic effects of deleterious alleles in the “motheaten” locus. Curr Top Microbiol Immunol 137:216–222
Shultz LD, Coman DR, Bailey CL, Beamer WG, Sidman CL (1984) “Viable motheaten”, a new allele in the motheaten locus. Am J Pathol 116:179–192
Su X, Zhou T, Yang P, Edwards CK III, Mountz JD (1998) Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor. Arthritis Rheum 41:139–149
Spontaneous Erythema in Hairless Rats
Chavaz P, Faucher F, Saurat JH (1984) Dermatosis of hairless rats fed with a hypomagnesic diet – pathology and immunology. Dermatologica 169:105–111
Iwamoto S, Nakayama H, Yasoshima A, Doi K (1997) Hydrogen peroxide-induced dermatitis in WBN/Kob-Ht rats. Exp Anim 46:147–151
Neckermann G, Bavandi A, Meingassner JG (2000) Atopic dermatitis-like symptoms in hypomagnesaemic hairless rats are prevented and inhibited by systemic or topical SDT ASM 981. Br J Dermatol 142:669–679
Tani S, Noguchi M, Hosada Y, Sugibayasi K, Morimoto Y (1998) Characteristics of spontaneous erythema appeared in hairless rats. Exp Anim 47:253–256
Spontaneous Atopic Dermatitis in Dogs
Nuttall TJ, Knight PA, McAleese SM, Lamb JR, Hill PB (2002) Expression of Th1, Th2 and immunosuppressive gene transcripts in canine atopic dermatitis. Clin Exp Allergy 32:789–795
Olivry T, Dunston SM, Murphy KM, Moore PF (2001) Characterization of the inflammatory infiltrate during IgE-mediated late phase reactions in the skin of normal and atopic dogs. Vet Dermatol 12:49–58
Scott DW, Miller WH, Griffin C (eds) (2001) Skin immune system and allergic skin disease. In: Muller & Kirk’s small animal dermatology. Saunders, Philadelphia, pp 534–666
Contact Hypersensitivity in Animals
Bilski AJ, Thomson DS (1984) Allergic contact dermatitis in the domestic pig. A new model for evaluating the topical anti-inflammatory activity of drugs and their formulations. Br J Dermatol 111(Suppl 27):143
Boyera N, Cavey D, Bouclier M, Burg G, Rossio P, Hensby C (1992) Repeated application of dinitrochlorobenzene to the ears of sensitized guinea pigs; a preliminary characterization of a potential new animal model for contact eczema in humans. Skin Pharmacol 5:184–188
Cooper KD (1994) Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 102:128–137
Corsini E, Galli CL (1998) Cytokines and irritant contact dermatitis. Toxicol Lett 102–103:277–282
Corsini AC, Bellucci SB, Costa MG (1979) A simple method of evaluating delayed type hypersensitivity in mice. J Immunol Methods 30:195–200
Ek L, Theodorsson E (1990) Tachykinins and calcitonin gene-related peptide in oxazolone-induced allergic contact dermatitis in mice. J Invest Dermatol 94:761–763
Fraginals R, Lepoittevin JP, Benezra C (1990) Sensitizing capacity of three methyl alkanesulphonates: a murine in vivo and in vitro model of allergic contact dermatitis. Arch Dermatol Res 282:455–458
Grabbe S, Steinbrink K, Steinert M, Luger TA, Schwarz T (1995) Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J Immunol 155:4207–4217
Heishi M, Imai Y, Katayama H, Hashida R, Ito M, Shinagawa A, Sugita Y (2003) Gene expression analysis of atopic dermatitis-like skin lesions induced in NC/Nga mice be mite antigen stimulation under specific pathogen-free conditions. Int Arch Allergy Immunol 132:356–363
Hsieh GC, Kolano RM, Andrews JW (1996) Immunosuppressant effects on improved guinea pig contact hypersensitivity (CH) model: induction with DNFB and elicitation with DNCB. FASEB J 10:A1221
Hsieh GC, Kolano RM, Gauvin DM (1997) Development of a swine contact hypersensitivity (CH) model – sensitization with DNFB and elicitation with DNCB for evaluating topical inhibitors. J Invest Dermatol 108:671
Katayama I, Tanei R, Yokozeki H, Nishioka K, Dohi Y (1990) Induction of eczematous skin reaction in experimentally induced hyperplastic skin of BALB/c mice by monoclonal anti-DNP IgE antibody: possible implications for skin lesion formation in atopic dermatitis. Int Arch Allergy Appl Immunol 93:148–154
Koyama Y, Kusubata M, Yoshiki A, Hiraiwa N, Ohashi T, Irie S, Kusukabe M (1998) Effect of tenascin-C deficiency on chemically induced dermatitis in the mouse. J Invest Dermatol 111:930–935
Laouini D, Alenius H, Bryce P, Oettgen H, Tsitsikov E, Geha RS (2003) IL-10 is critical for Th2 response in a murine model of allergic dermatitis. J Clin Invest 112:1058–1066
Lavaud P, Rodrigue F, Carre C, Touvay C, Mencia-Huerta JM, Braquet P (1991) Pharmacological modulation of picryl chloride-induced contact dermatitis in the mouse. J Invest Dermatol 97:101–105
Leung DM (1997) Atopic dermatitis: immunobiology and treatment with immune modulators. Clin Exp Immunol 107:25–30
Li XM, Kleiner G, Huang CK, Lee SY, Schofield B, Soter NA, Sampson HA (2001) Murine model of atopic dermatitis associated with food hypersensitivity. J Allergy Clin Immunol 107:693–702
Lowe NJ, Virgadamo F, Stoughton RB (1977) Anti-inflammatory properties of a prostaglandin antagonist, a corticosteroid and indomethacin in experimental contact dermatitis. Br J Dermatol 96:433–438
Maguire HC (1996) Cyclophosphamide and interleukin-12 synergistically upregulate the acquisition of allergic contact dermatitis in the mouse. Acta Derm Venereol 76:277–279
Matsui K, Nishikawa A (2002) Lipoteichoic acid from Staphylococcus aureus induces Th2-prone dermatitis in mice sensitized percutaneously with allergen. Clin Exp Allergy 32:783–788
Matsuoka H, Maki N, Yoshida S, Arai M, Wang J, Oikawa Y, Ikeda T, Hirota N, Nakagawa H, Ishii A (2001) A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae. Allergy 58:139–145
Meingassner JG, Stütz A (1992) Immunosuppressive macrolides of the type FK 506: a novel class of topical agents for treatment of skin diseases? J Invest Dermatol 98:851–855
Meingassner JG, Grassberger M, Fahrngruber H, Moore HD, Schuurman H, Stütz A (1997) A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology. Br J Dermatol 137:568–576
Morita E, Kaneko S, Hiragun T, Shindo H, Tanaka T, Furukawa T, Nobukiyo A, Yamamto S (1999) Fur mites induce dermatitis associated with IgE hyperproduction in an inbred strain of mice, NC/Kuj. J Dermatol Sci 19:37–43
Rosenqvist U, Persson K, Lindgren BR, Andersson RG (1991) Effects of cilazaprilat and enalaprilat on experimental dermatitis in guinea pigs. Pharmacol Toxicol 68:404–407
Sasakawa T, Higashi Y, Sakuma S, Hirayama Y, Sasakawa Y, Ohkubo Y, Goto T, Matsumoto M, Matsuda H (2001) Atopic dermatitis-like lesions induced by topical application of mite antigens in NC/Nga mice. Int Arch Allergy Immunol 126:239–247
Shoji Y, Fukumura T, Kudo M, Yanagawa A, Shimada J, Mizushima Y (1994) Effect of topical preparation of mycophenolic acid on experimental allergic contact dermatitis of guinea pigs induced by dinitrofluorobenzene. J Pharm Pharmacol 46:643–646
Sicherer SH, Sampson HA (1999) Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis and management. J Allergy Clin Immunol 104:114–122
Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS (1998) Epicutaneous sensitization with protein antigen induced localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 101:1614–1622
Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, Geha RS (1999) Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 103:11034–1111
Stanley PL, Steiner S, Havens M, Tramposch KM (1991) Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate. Skin Pharmacol 4:262–271
Takeshita K, Yamasaki T, Akira S, Gantner F, Bacon KB (2004) Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse. Int Immunol 16:685–695
Traidl C, Jugert F, Krieg T, Merk H, Hunzelmann N (1999) Inhibition of allergic contact dermatitis to DNCB but not to oxazolone in interleukin-4 deficient mice. J Invest Dermatol 112:476–482
Trenam CW, Dabbagh AJ, Morris CJ, Blake DR (1991) Skin inflammation induced by reactive oxygen species (ROS): an in vivo model. Br J Dermatol 125:325–329
Vana G, Meingassner JG (2000) Morphologic and immunohistochemical features of experimentally induced contact dermatitis in Göttingen minipigs. Vet Pathol 37:565–580
Non-Immunologic Contact Urticaria
Lathi A, Maibach HI (1984) An animal model of nonimmunologic contact urticaria. Toxicol Appl Pharmacol 76:219–234
Lauerma AI, Fenn B, Maibach HI (1997) Trimellitic anhydride-sensitive mouse as an animal model for contact urticaria. J Appl Toxicol 17:357–360
Maibach HI, Johnson HL (1975) Contact urticaria syndrome. Contact urticaria to diethyltoluamide (immediate-type hypersensitivity). Arch Dermatol 111:426–434
Meingassner JG, Stütz A (1992) Anti-inflammatory effects of macrophilin-interacting drugs in animal models of irritant and allergic contact dermatitis. Int Arch Allergy Immunol 99:486–489
Mononuclear Cells from Atopic Dermatitis Donors
Hong G, Davis B, Khattoon N, Baker SF, Brown J (2003) PPARγ-dependent anti-inflammatory action of rosiglitazone in human monocytes: suppression of TNFα secretion is not mediated by PTEN regulation. Biochem Biophys Res Commun 303:782–787
Rühl R, Dahten A, Schweigert FJ, Herz U, Worm M (2003) Inhibition of IgE-production by peroxisome proliferator-activated ligands. J Invest Dermatol 121:757–764
Sperhake K, Neuber K, Enssle K, Ring J (1998) Effects of recombinant human soluble interleukin-4 receptor on interleukin-4/staphylococcal enterotoxin B-stimulated peripheral mononuclear cells from patients with atopic eczema. Br J Dermatol 139:784–790
The SCID-hu Skin Mouse as Model for Atopic Dermatitis
Biedermann T, Schwärzler C, Lametschwandtner G, Thoma G, Carballido-Perrig N, Kund J, de Vries JE, Rot A, Carballido JM (2002) Targeting CLA/E-Selectin interactions prevents CCR4 mediated recruitment of human Th2 memory cells to human skin in vivo. Eur J Immunol 32:3171–3180
Biedermann T, Röcken M, Carballido JM (2004) TH1 and TH2 lymphocyte development and regulation of TH cell-mediated immune responses of the skin. J Investig Dermatol Symp Proc 9:5–14
Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301:527–530
Carballido JM, Aversa G, Kaltoft K, Cocks BG, Punnonen J, Yssel H, Thestrup-Pedersen K, de Vries JE (1997) Reversal of human allergic T helper 2 responses by engagement of signaling lymphocytic activation molecule. J Immunol 159:4316–4321
Carballido JM, Namikawa R, Carballido-Perrig N, Antonenko S, Roncarolo MG, de Vries JE (2000) Generation of primary antigen-specific human T- and B-cell responses in immunocompetent SCID-hu mice. Nat Med 6:103–106
Carballido JM, Biedermann T, Schwärzler C, de Vries JE (2003) The SCID-hu skin mouse as a model to investigate selective chemokine mediated homing of human T-lymphocytes to the skin in vivo. J Immunol Methods 273:125–135
Igney FH, Asadullah K, Zollner TM (2004) Techniques: species’ finest blend – humanized mouse models in inflammatory skin disease research. Trends Pharmacol Sci 25:543–549
Lametschwandtner G, Biedermann T, Schwärzler C, Günther C, Kund J, Fassl S, Hinteregger S, Carbadillo-Perrig N, Szabo SJ, Glimcher LH, Carbadillo JM (2004) Sustained T-bet expression confers polarized human TH2 cells with TH1-like cytokine production and migratory capacities. J Allergy Clin Immunol 113:987–994
Robert C, Kupper TS (1999) Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 341:1817
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this entry
Cite this entry
Maibach, H. (2016). Experimental Dermatitis. In: Hock, F. (eds) Drug Discovery and Evaluation: Pharmacological Assays. Springer, Cham. https://doi.org/10.1007/978-3-319-05392-9_95
Download citation
DOI: https://doi.org/10.1007/978-3-319-05392-9_95
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-05391-2
Online ISBN: 978-3-319-05392-9
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences